109904-37-2 Usage
Uses
Used in Pharmaceutical Industry:
5,6,7,7a-Tetrahydrothieno[3,2-c]pyridin-2(4H)-one is used as a potential anticonvulsant agent for the treatment of seizure disorders. Its neuroprotective properties make it a candidate for further research and development in managing neurological conditions.
Used in Neurological Disorders Treatment:
In the field of neurology, 5,6,7,7a-Tetrahydrothieno[3,2-c]pyridin-2(4H)-one is being investigated for its potential role in treating various neurological disorders. Its pharmacological profile suggests it may offer therapeutic benefits in conditions that require neuroprotection and seizure management.
Used in Organic Synthesis:
5,6,7,7a-Tetrahydrothieno[3,2-c]pyridin-2(4H)-one serves as a valuable chemical building block in organic synthesis. Its unique structure allows for the development of new compounds with potential applications in various industries, including pharmaceuticals, agrochemicals, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 109904-37-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,9,9,0 and 4 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 109904-37:
(8*1)+(7*0)+(6*9)+(5*9)+(4*0)+(3*4)+(2*3)+(1*7)=132
132 % 10 = 2
So 109904-37-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H9NOS/c9-7-3-5-4-8-2-1-6(5)10-7/h3,6,8H,1-2,4H2
109904-37-2Relevant academic research and scientific papers
Derivatives of alpha-(2-oxo 2,4,5,6,7,7a-hexahydro thieno[3,2-c]5-pyridyl) phenyl acetic acid, and their use as platelet and thrombotic aggregation inhibitors
-
, (2008/06/13)
The present invention relates to novel derivatives of alpha-(2-oxo 2,4,5,6,7,7a-hexahydro thieno [3,2-c] 5-pyridyl) phenyl acetic acid corresponding to the following general formula: STR1 their addition salts with pharmaceutically-acceptable inorganic or organic acids as well as isomers and their mixtures. The invention also relates to their process of preparation and to medicaments containing these compounds which are of therapeutic use as inhibitors of platelet- and thrombotic-aggregation.
